Masonic Cancer Center receives five-year program project research grants from NCI

Download PDF Copy

Reviewed

University of MinnesotaSep 23 2010

Findings will benefit thousands of patients diagnosed worldwide with leukemia, other cancers and disorders

Two of the University of Minnesota Masonic Cancer Center's leading physician-scientists on research and treatment of cancers of the blood and bone marrow - Philip McGlave, M.D., and Jeffrey Miller, M.D., -- have received renewed five-year program project research grants totaling almost $26 million from the National Cancer Institute (NCI).

McGlave and Miller will use the grants to lead research teams focused on increasing the availability, safety, and effectiveness of hematopoietic stem cell transplantation and cell therapies to improve treatment and survival for the thousand of patients diagnosed annually with leukemia, lymphoma, multiple myeloma and other blood and bone marrow disorders.

Source:

University of Minnesota

Posted in: Medical Research News | Medical Condition News

Comments (0)

Download PDF Copy

Suggested Reading

Loneliness and isolation associated with higher death risk in cancer patients

Engineered antibody triggers powerful anti-tumor response in advanced cancers

Bridging innovation and equity to end cervical cancer worldwide

Breakthrough in cancer therapy targets key protein interaction to suppress tumors

Blocking two enzymes weakens prostate tumors and boosts drug effectiveness

Study reveals acidic conditions as key to pancreatic cancer survival

New imaging technique boosts survival in prostate cancer patients

Fatty acids found to be a primary driver of triple-negative tumor growth

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

(Logout)

Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.